Pancreatic Cancer Research

ResearcherSelçuk UniversityActive in the last 2 years

Duygu Dursunoğlu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4414-8659; OpenAlex author ID A5035391036. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 1 paper

Papers 3

  1. The Effects of Juglone on Cell Proliferation and Insulin-Like Growth Factor I Receptor/Phosphoinositide 3-Kinase/p85 (IGF-IR/PI3K/p85) Signaling Pathway in Pan… Co-author DOI 10.14744/cpr.2025.50464↗
  2. Juglone-ascorbate treatment enhances reactive oxygen species mediated mitochondrial apoptosis in pancreatic cancer. Co-author DOI 10.1007/s11033-024-09254-6↗
  3. The effects of Juglone-Selenium combination on invasion and metastasis in pancreatic cancer cell lines. First author DOI 10.4314/ahs.v22i2.37↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hilal Arıkoğlu · 2 shared papers, 2022–2024 · strength 0.50
  2. Dudu Erkoç Kaya · 2 shared papers, 2022–2024 · strength 0.50
  3. Ebru Güçlü · 1 shared paper, 2024 · strength 0.28
  4. Esma Menevşe · 1 shared paper, 2024 · strength 0.28
  5. Ebru Avcı · 1 shared paper, 2022 · strength 0.22

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.